1. Guidelines on the management of valvular heart disease (version 2012). European Heart Journal 2012; 33: 2451-96.
2. Faggiano P, Antonini-Canterin F, Baldessin F, et al. Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovascular Ultrasound 2006; 4: 27.
3. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis a disease of the valve and the myocardium. J Am Coll Cardiol 2012; 60 (19): 1854-63.
4. Nikitina IL, Karonova TL, Grineva EN. Vitamin D deficiency and health. Arterial Hypertension. 2010; 16(3): 277-81. Russian (Никитина И. Л., Каронова Т. Л., Гринева Е. Н. Дефицит витамина Д и здоровье. Артериальная гипертензия. 2010; 16 (3): 277-81).
5. Kutikhin AG, Yuzhanin AE, Brusina EB, et al. Genetic predisposition to calcific aortic stenosis and mitral annular calcification. Mol Biol Rep 2014; 41 (9): 5645-63.
6. Bover J, Egido J, Fernadez-Giraldez E, et al. Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease. Nefrologia 2015; 35(1): 28-41.
7. Spasovski GB. Bone health and vascular calcification relationships in chronic kidney disease. Int Urol Nephrol 2007; 39(4): 1209-16.
8. Bouillon R, Carmeliet G, Verlinden L. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine Reviews 2008; 29(6): 726-76.
9. Osuga T, Nakamura K, Norita T, et al. Vitamin D Status in Different Stages of Disease Severity in Dogs with Chronic Valvular Heart Disease. J Vet Intern Med 2015; 29(6): 1518-23.
10. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96(7): 1911-30.
11. Pigarova EA, Rozhinskaya LYa, Belaya ZE, et al. Clinical guidelines of Russian association of endocrinologists. Vitamin D deficiency in adults: diagnosis, treatment and prevention. Problemy Endocrinologii 2016; 62 (4): 60-84. Russian (Пигарова Е. А., Рожинская Л. Я., Белая Ж. Е. и др. Клинические рекомендации Российской ассоциации эндокринологов. Дефицит витамина D у взрослых: диагностика, лечение и профилактика. Проблемы эндокринологии 2016; 62 (4): 60-84).
12. Lesnyak OM, Nikitinskaya OA, Toroptsova NV, et al. Prevention, diagnosis and treatment of vitamin D deficiency and calcium in the adult population of Russia, and patients with osteoporosis (based on clinical guidelines produced). Scientific and practical rheumatology. 2015; 53(4): 403-8. Russian (Лесняк О. М., Никитинская О. А., Торопцова Н. В. и др. Профилактика, диагностика и лечение дефицита витамина D и кальция у взрослого населения России и пациентов с остеопорозом (по материалам подготовленных клинических рекомендаций). Научно-практическая ревматология. 2015; 3(4): 403-8).
13. Brandenburg VM, Vervloet MG, Marx N. The role of vitamin D in cardiovascular disease: From present evidence to future perspectives. Atherosclerosis 2012; 225: 253-63.
14. Stechschulte SA, Kirsner RS, Federman DG. Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med 2009; 122: 793-802.
15. De Boer IH, Kestenbaum B, Shoben AB, et al. 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 2009; 20: 1805-12.
16. Karonova TL, Grineva EN, Nikitina IL, et al. The prevalence of vitamin D deficiency in the Northwest region of Russia among the residents of St. Petersburg and Petrozavodsk. Osteoporosis and osteopathy. 2013; 3: 3-7. Russian (Каронова Т. Л., Гринева Е. Н., Никитина И. Л. и др. Распространенность дефицита витамина D в Северо-Западном регионе РФ среди жителей г. Санкт-Петербурга и г. Петрозаводска. Остеопороз и остеопатии 2013; 3: 3-7).
17. Linhartova K, Veselka J, Sterbakova G, et al. Parathyroid hormone and vitamin D levels are independently associated with calcific aortic ctenosis. Circ J 2008; 72: 245-50.
18. Akat K, Kaden JJ, Schmitz F, et al. Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. Am J Cardiol 2010; 105(6): 862-4.
19. Kienreich K, Tomaschitz A, Verheyen N. Vitamin D and cardiovascular disease. Nutrients 2013; 5: 3005-21.
20. Skaaby T, Husemoen LL, Pisinger C, et al. Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general population. Cardiology 2012; 123(1): 62-70.
21. Rajamannan NM. Calcific aortic stenosis: lessons learned from experimental and clinical studies. Arterioscler Thromb Vasc Biol 2009; 29: 162-8.
22. Wong MS, Leisegang MS, Kruse C, et al. Vitamin D promotes vascular regeneration. Circulation 2014; 130: 976-86.
23. Yu PJ, Skolnick A, Ferrari G, et al. Correlation between plasma osteopontin levels and aortic valve calcification: Potential insights into the pathogenesis of aortic valve calcification and stenosis. J Thorac Cardiovasc Surg 2009; 138: 196-9.
24. Grau JB, Poggio P, Sainger R, et al. Analysis of osteopontin levels for the identification of asymptomatic patients with calcific aortic valve disease. Ann Thorac Surg 2012; 93(1): 79-86.
25. Kapelouzou A, Tsourelis L, Kaklamanis L, et al. Serum and tissue biomarkers in aortic stenosis. Glob Cardiol Sci Pract 2015; 2015(4): 49.
26. Tastet L, Capoulade R, Clavel MA, et al. Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study. Eur Heart J Cardiovasc Imaging 2016. http://ehjcimaging.oxfordjournals.org/content/early/2016/02/18/ehjci.jew013.long (18 Feb 2016).
27. Amer M, Qayyum R. Relation Between Serum 25-Hydroxyvitamin D and C-Reactive Protein in Asymptomatic Adults (From the Continuous National Health and Nutrition Examination Survey 2001 to 2006). Journal of the American College of Cardiology 2012; 109: 226-30.
28. Chen N, Wan Z, Han SF, et al. Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients 2014; 6(6): 2206-16.